Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions

Overview of attention for article published in Frontiers in Pharmacology, July 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 52 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,992 followers.

RT @ApolloHealthGr2: Recent pharmacogenomic studies have revealed strong associations between SCAR and drug-metabolizing enzymes. Updating…

21 Apr 2022

Reply Repost Favourite

Recent pharmacogenomic studies have revealed strong associations between SCAR and drug-metabolizing enzymes. Updating the current knowledge in the field of pharmacogenomics of drug hypersensitivities and its implementation in clinical practices. Source: h

20 Apr 2022

Reply Repost Favourite

New Research: Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions https://t.co/TQTzOuC5zr #pharmacology

08 Aug 2020

Reply Repost Favourite

Check out this OA review on genetic markers for severe cutaneous adverse reactions (SCAR). Although the incidence of SCAR is low, they can be potentially lethal events. #Abacavir #Allopurinol #G6PD #HLA #pharmacogenomics https://t.co/MWog107IcL

02 Aug 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.